Tag Archives: Outcomes

AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study

Now that AstraZeneca has scored its Farxiga outcomes data, it’s aiming to change the game on its SGLT2 diabetes rivals. First up? Expanding its salesforce to prepare for a full-court press on doctors.  The British drugmaker aims to “increase the scope” of its physician marketing after phase 3 trial data showed Farxiga cut the risk of cardiovascular… Read More »

Lithium and Anticonvulsant Mood Stabilizers: No Higher Risk for Adverse Pregnancy Outcomes

For women with bipolar disorder, choosing whether to maintain or discontinue treatment with a mood stabilizer during pregnancy is challenging.  This is a process which requires careful and thoughtful consideration, weighing the risk of adverse outcomes associated with exposure to a particular drug against the risk of recurrent illness in the setting of medication discontinuation.… Read More »

Private equity gobbles up dermatology practices, raising questions about outcomes, costs

Dive Brief: Fewer dermatologists are working solo compared to a decade ago as private equity has upped its stake in dermatology practices nationwide, according to a new report in JAMA Dermatology. The latest study found 17 different PE groups acquired 184 practices over a six-year period, snapping up about 381 clinics overall. PE acquisitions helped… Read More »

For Black Men With Prostate Cancer, Equal Access Means Equal Outcomes

Equal access to care and standardized treatment result in similar outcomes among white and Black men with prostate cancer, suggest new findings published in JAMA Oncology, reports Healio. Black men are more likely to be diagnosed with prostate cancer, especially more aggressive forms, and more likely to die of the disease than white men. But… Read More »

Research expected to help cull outcomes in claims and EHR data

The National Science Foundation has awarded a $ 224,793 grant to Vanguard Medical Technologies, an incubation firm, to find outcomes data for researchers. The firm is charged with developing technology that will enable clinical trials to use artificial intelligence to dive into an electronic health records system and cull out useful data. As regulatory bodies… Read More »